Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Omoomi FD"'
Autor:
Mojarrad P; Faculty of Pharmacy, International Campus, Tehran University of Medical Sciences International Campus (TUMS-IC), Tehran, Iran., Zamani S; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Seyedhamzeh M; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m.s.hamzeh@gmail.com., Omoomi FD; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Karimpourfard N; Faculty of Pharmacy, International Campus, Tehran University of Medical Sciences International Campus (TUMS-IC), Tehran, Iran., Hadadian S; Nano-Biotechnology Department of Pasteure Institute of Iran, Tehran, Iran., Ebrahimi SES; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Hamedani MP; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Farzaneh J; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: jafarfarzaneh97@gmail.com., Ardestani MS; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: shafieeardestani@tums.ac.ir.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2020 Jan 01; Vol. 141, pp. 105112. Date of Electronic Publication: 2019 Oct 17.
Autor:
Tabasi MA; Department Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran and Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. shafieeardestani@gmail.com., Amanlou M, Siadat SD, Nourmohammadi Z, Omoomi FD, Ebrahimi SE, Aghasadeghi MR, Rahimi P, Pourhosseini S, Mehravi B, Ardestani MS
Publikováno v:
Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2013 Nov; Vol. 13 (9), pp. 1449-59.
Autor:
Mohtavinejad, Naser1, Hajiramezanali, Maliheh2, Akhlaghi, Mehdi3, Bitarafan-Rajabi, Ahmad4,5, Gholipour, Nazila1,6 nazilagholipour@bmsu.ac.ir
Publikováno v:
Iranian Journal of Basic Medical Sciences. Nov2021, Vol. 24 Issue 11, p1488-1499. 12p.
Autor:
Khosravian, Pegah1, Ardestani, Mehdi Shafiee2, Khoobi, Mehdi3, Ostad, Seyed Naser4, Dorkoosh, Farid Abedin1, Javar, Hamid Akbari1 akbarijo@tums.ac.ir, Amanlou, Massoud5,6 amanlou@tums.ac.ir
Publikováno v:
OncoTargets & Therapy. 2016, Vol. 9, p7315-7329. 15p.
Autor:
Assadi, Artin1, Najafabadi, Vahideh Sharifi1 shafieeardestani@tums.ac.ir, Sadat Shandiz, Seyed Ataollah2, Boroujeni, Azadah Shayeq1, Ashrafi, Sepehr1, Vaziri, Ali Zaman1, Ghoreishi, Seyedeh Masoumeh3, Aghasadeghi, Mohammad Reza4, Sadat Ebrahimi, Seyed Esmaeil1, Pirali-Hamedani, Morteza4, Ardestani, Mehdi Shafiee1
Publikováno v:
OncoTargets & Therapy. Sep2016, Vol. 9, p5531-5543. 13p.
New Strategies Targeting Cancer Metabolism: Anticancer Drugs, Synthetic Analogues and Antitumor Agents presents up-to-date synthetic strategies for three categories of antimetabolites: antifolates, purines and pyrimidines, the main classes of antimet